USFDA APPLICATION NUMBER - 21169 / DOSAGE - TABLET;ORAL - EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
galantamine hydrobromide(UNII: MJ4PTD2VVW) (galantamine - UNII:0D3Q044KCA) | galantamine | 12mg |
Inactive Ingredients
Ingredient Name | Avera McKennan Hospital | Janssen Pharmaceuticals, Inc. |
---|---|---|
aluminum oxide(LMI26O6933) | ||
cellulose, microcrystalline(OP1R32D61U) | ||
CROSPOVIDONE (120 .MU.M)(68401960MK) | ||
crospovidone (15 mpa.s at 5%)(68401960MK) | ||
crospovidone(68401960MK) | ||
D&C Yellow No. 10(35SW5USQ3G) | ||
diethyl phthalate(UF064M00AF) | ||
ethylcellulose, unspecified(7Z8S9VYZ4B) | ||
ferric oxide red(1K09F3G675) | ||
ferric oxide yellow(EX438O2MRT) | ||
gelatin, unspecified(2G86QN327L) | ||
hypromellose, unspecified(3NXW29V3WO) | ||
hypromelloses(3NXW29V3WO) | ||
lactose monohydrate(EWQ57Q8I5X) | ||
magnesium stearate(70097M6I30) | ||
MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | ||
polyethylene glycol, unspecified(3WJQ0SDW1A) | ||
silicon dioxide(ETJ7Z6XBU4) | ||
talc(7SEV7J4R1U) | ||
titanium dioxide(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?